These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26183767)

  • 1. CD4+CXCR3+ T cells and plasmacytoid dendritic cells drive accelerated atherosclerosis associated with systemic lupus erythematosus.
    Clement M; Charles N; Escoubet B; Guedj K; Chauveheid MP; Caligiuri G; Nicoletti A; Papo T; Sacre K
    J Autoimmun; 2015 Sep; 63():59-67. PubMed ID: 26183767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of CCR2 and CXCR3 in the T cell-mediated response occurring during lupus flares.
    Amoura Z; Combadiere C; Faure S; Parizot C; Miyara M; Raphaël D; Ghillani P; Debre P; Piette JC; Gorochov G
    Arthritis Rheum; 2003 Dec; 48(12):3487-96. PubMed ID: 14673999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease trends over time and CD4
    Baragetti A; Ramirez GA; Magnoni M; Garlaschelli K; Grigore L; Berteotti M; Scotti I; Bozzolo E; Berti A; Camici PG; Catapano AL; Manfredi AA; Ammirati E; Norata GD
    Nutr Metab Cardiovasc Dis; 2018 Jan; 28(1):53-63. PubMed ID: 29150407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCR3+CD4+ T cells are enriched in inflamed kidneys and urine and provide a new biomarker for acute nephritis flares in systemic lupus erythematosus patients.
    Enghard P; Humrich JY; Rudolph B; Rosenberger S; Biesen R; Kuhn A; Manz R; Hiepe F; Radbruch A; Burmester GR; Riemekasten G
    Arthritis Rheum; 2009 Jan; 60(1):199-206. PubMed ID: 19116922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic lupus erythematosus aggravates atherosclerosis by promoting IgG deposition and inflammatory cell imbalance.
    Liu T; Shi N; Zhang S; Silverman GJ; Duan XW; Zhang S; Niu H
    Lupus; 2020 Mar; 29(3):273-282. PubMed ID: 32075511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic Cells in Systemic Lupus Erythematosus: From Pathogenic Players to Therapeutic Tools.
    Klarquist J; Zhou Z; Shen N; Janssen EM
    Mediators Inflamm; 2016; 2016():5045248. PubMed ID: 27122656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sialic acid-binding immunoglobulin-type lectin H-positive plasmacytoid dendritic cells drive spontaneous lupus-like disease development in B6.Nba2 mice.
    Davison LM; Jørgensen TN
    Arthritis Rheumatol; 2015 Apr; 67(4):1012-22. PubMed ID: 25504931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients.
    Wu P; Wu J; Liu S; Han X; Lu J; Shi Y; Wang J; Lu L; Cao X
    Clin Immunol; 2008 Oct; 129(1):40-8. PubMed ID: 18684674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic and stromal cells from the spleen of lupic mice present phenotypic and functional abnormalities.
    Gleisner MA; Reyes P; Alfaro J; Solanes P; Simon V; Crisostomo N; Sauma D; Rosemblatt M; Bono MR
    Mol Immunol; 2013 Jul; 54(3-4):423-34. PubMed ID: 23428837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual effects of statins therapy in systemic lupus erythematosus and SLE-related atherosclerosis: the potential role for regulatory T cells.
    Tu H; Li Q; Xiang S; Jiang H; Mao Y; Shou Z; Chen J
    Atherosclerosis; 2012 May; 222(1):29-33. PubMed ID: 22417842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus.
    Bruce IN
    Rheumatology (Oxford); 2005 Dec; 44(12):1492-502. PubMed ID: 16234277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerogenic dendritic cells: role and therapeutic implications in systemic lupus erythematosus.
    Mok MY
    Int J Rheum Dis; 2015 Feb; 18(2):250-9. PubMed ID: 25639676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus.
    Blomberg S; Eloranta ML; Magnusson M; Alm GV; Rönnblom L
    Arthritis Rheum; 2003 Sep; 48(9):2524-32. PubMed ID: 13130472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced immune system activation and arterial inflammation accelerates atherosclerosis in lupus-prone mice.
    Gautier EL; Huby T; Ouzilleau B; Doucet C; Saint-Charles F; Gremy G; Chapman MJ; Lesnik P
    Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1625-31. PubMed ID: 17446440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic Lupus Erythematosus and Endothelial Dysfunction: A Close Relationship.
    Sciatti E; Cavazzana I; Vizzardi E; Bonadei I; Fredi M; Taraborelli M; Ferizi R; Metra M; Tincani A; Franceschini F
    Curr Rheumatol Rev; 2019; 15(3):177-188. PubMed ID: 30474532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD134 expression on CD4+ T cells is associated with nephritis and disease activity in patients with systemic lupus erythematosus.
    Patschan S; Dolff S; Kribben A; Dürig J; Patschan D; Wilde B; Specker C; Philipp T; Witzke O
    Clin Exp Immunol; 2006 Aug; 145(2):235-42. PubMed ID: 16879242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-I Mediates Dysfunction of Endothelial Progenitor Cells in Atherosclerosis of Systemic Lupus Erythematosus.
    Ding X; Xiang W; He X
    Front Immunol; 2020; 11():581385. PubMed ID: 33262760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Enhanced Expression Level of CXCR3 on Tfh-like Cells from Lupus Skin Lesions Rather Than Lupus Peripheral Blood.
    Yang M; Cao P; Zhao Z; Wang Z; Jia C; Guo Y; Yin H; Zhao M; Ding Y; Wu H; Lu Q
    Clin Immunol; 2021 May; 226():108717. PubMed ID: 33775870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated circulating CD4+ ICOS+ Foxp3+ T cells contribute to overproduction of IL-10 and are correlated with disease severity in patients with systemic lupus erythematosus.
    Liu Y; Zhu T; Cai G; Qin Y; Wang W; Tang G; Zhao D; Shen Q
    Lupus; 2011 May; 20(6):620-7. PubMed ID: 21558138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic lupus erythematosus patients have increased number of circulating plasmacytoid dendritic cells, but decreased myeloid dendritic cells with deficient CD83 expression.
    Jin O; Kavikondala S; Sun L; Fu R; Mok MY; Chan A; Yeung J; Lau CS
    Lupus; 2008 Jul; 17(7):654-62. PubMed ID: 18625638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.